<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1684-1824</journal-id>
<journal-title><![CDATA[Revista Médica Electrónica]]></journal-title>
<abbrev-journal-title><![CDATA[Rev.Med.Electrón.]]></abbrev-journal-title>
<issn>1684-1824</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Ciencias Médicas de Matanzas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1684-18242024000100034</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Necesidad de calcular el riesgo cardiovascular global en pacientes hipertensos]]></article-title>
<article-title xml:lang="en"><![CDATA[Need to calculate global cardiovascular risk in hypertensive patients]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez-Cruz]]></surname>
<given-names><![CDATA[Maricela]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Afonso-de-León]]></surname>
<given-names><![CDATA[José Alberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Morera-Galbán]]></surname>
<given-names><![CDATA[Yailin]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Universitario Clínico Quirúrgico Comandante Faustino Pérez Hernández  ]]></institution>
<addr-line><![CDATA[ Matanzas]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de Ciencias Médicas de Matanzas  ]]></institution>
<addr-line><![CDATA[ Matanzas]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Policlínico Docente José Jacinto Milanés  ]]></institution>
<addr-line><![CDATA[ Matanzas]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<volume>46</volume>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1684-18242024000100034&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1684-18242024000100034&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1684-18242024000100034&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN Ante la amenaza para la salud que representan las enfermedades cardiovasculares, la iniciativa HEARTS, de la Organización Mundial de Salud, brinda apoyo a los países para que fortalezcan las medidas destinadas a prevenir las enfermedades cardiovasculares, como la estratificación del riesgo cardiovascular. Los autores proponen como objetivo fundamentar la necesidad del cálculo del riesgo cardiovascular global en la atención primaria de salud. Para estimar el riesgo cardiovascular global se utilizan dos formas: la cualitativa y la cuantitativa. En esta última, se consideran determinados factores de riesgo cardiovascular, que se expresa en términos de bajo, medio y alto. Existen varios sistemas en diferentes soportes que permiten su uso en diversos escenarios; además, posibilitan planificar el seguimiento y el tratamiento de acuerdo al riesgo. Aunque tienen desventajas, su uso es recomendable para prevenir complicaciones y muerte. El cálculo del riesgo cardiovascular global en pacientes hipertensos es una medida de gran valor para predecir mortalidad, establecer la estrategia terapéutica y planificar el seguimiento de los pacientes. Su uso debe extenderse y consolidarse a todos los niveles de la atención de salud.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT Faced with the global health threat posed by cardiovascular diseases, the HEARTS initiative of the World Health Organization supports countries to strengthen measures to prevent cardiovascular diseases, such as cardiovascular risk stratification. The authors propose as an objective to substantiate the need of calculating global cardiovascular risk in primary health care. Two forms are used to estimate global cardiovascular risk: qualitative and quantitative. In the latter, certain cardiovascular risk factors are considered and expressed in terms of low, medium, and high risk. There are several systems and in different supports that allow their use in various scenarios; in addition they make it possible to plan the follow-up and treatment according to risk. Although they have disadvantages, their use is recommended to prevent complications and death. The calculation of global cardiovascular risk in hypertensive patients is a measure of great value for predicting mortality, establishing the therapeutic strategy, and planning patient follow-up. Its use should be extended and consolidated at all levels of health care.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[hipertensión arterial]]></kwd>
<kwd lng="es"><![CDATA[estratificación de riesgo cardiovascular]]></kwd>
<kwd lng="en"><![CDATA[arterial hypertension]]></kwd>
<kwd lng="en"><![CDATA[cardiovascular risk stratification]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Es hora de actuar: Informe de la comisión independiente de alto nivel de la OMS sobre enfermedades no trasmisibles]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[OMS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bonet Gorbea]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Varona Pérez]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[III Encuesta nacional de factores de riesgo y actividades preventivas de enfermedades no trasmisibles. Cuba 2010-2011]]></source>
<year>2014</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Editorial Ciencias Médicas]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[The Global Hearts Initiative Working Together to Promote Cardiovascular Health]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Al-Makki]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[DiPette]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Whelton]]></surname>
<given-names><![CDATA[PK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hypertension pharmacological treatment recommendations in adults. A World Health Organization guidelines executive summary]]></article-title>
<source><![CDATA[Hypertension]]></source>
<year>2022</year>
<volume>79</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>293-301</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Orduñez]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Tajer]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Gaziano]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La aplicación HEARTS: una herramienta clínica para el manejo del riesgo cardiovascular y la hipertensión en la atención primaria de salud]]></article-title>
<source><![CDATA[Rev Panam Salud Pública]]></source>
<year>2022</year>
<volume>46</volume>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pérez Caballero]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Valdés González]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez Perea]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Hipertensión arterial en el adulto. Guía de actuación para la atención primaria de salud]]></source>
<year>2021</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Salud Pública]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<collab>Organización Panamericana de la Salud</collab>
<source><![CDATA[Calculadora de riesgo cardiovascular]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Washington DC ]]></publisher-loc>
<publisher-name><![CDATA[OPS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castaño Cifuentes]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Hoyos Zuluaga]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Palacios Cuesta]]></surname>
<given-names><![CDATA[MY]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antecedentes, hábitos, características de género y escalas de riesgo cardiovascular en trabajadores hospitalarios]]></article-title>
<source><![CDATA[Rev Asoc Esp Espec Med Trab]]></source>
<year>2022</year>
<volume>31</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>41-9</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alcocer]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Lozada]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Fanghänel]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global cardiovascular risk stratification: comparison of the Framingham method with the SCORE method in the Mexican population]]></article-title>
<source><![CDATA[Cir Cir]]></source>
<year>2011</year>
<volume>79</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>168-74</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lu]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Cui]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study]]></article-title>
<source><![CDATA[Eur Heart J]]></source>
<year>2022</year>
<volume>43</volume>
<numero>18</numero>
<issue>18</issue>
<page-range>1702-11</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gort-Hernández]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mamane-Malam]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Márquez-Blanco]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Categoría de riesgo cardiovascular total en pacientes hipertensos]]></article-title>
<source><![CDATA[Rev Cienc Méd Pinar Río]]></source>
<year>2023</year>
<volume>27</volume>
<numero>0</numero>
<issue>0</issue>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hechavarría Matos]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Montes de Oca Carmenaty]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Chaveco Bello]]></surname>
<given-names><![CDATA[LL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estimación del riesgo cardiovascular total en pacientes con hipertensión arterial]]></article-title>
<source><![CDATA[Inmedsur]]></source>
<year>2020</year>
<volume>3</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>23-31</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díaz-Esquivel]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Pereda-Rodríguez]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Linares-Montano]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estimación del riesgo cardiovascular en pacientes hipertensos. Policlínico Docente Universitario Luis Augusto Turcios Lima, 2021]]></article-title>
<source><![CDATA[Rev Cienc Méd Pinar Río]]></source>
<year>2022</year>
<volume>26</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dueñas-Herrera]]></surname>
<given-names><![CDATA[AF]]></given-names>
</name>
<name>
<surname><![CDATA[Armas-Rojas]]></surname>
<given-names><![CDATA[NB]]></given-names>
</name>
<name>
<surname><![CDATA[Prohias-Martínez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Determinación del Riesgo Cardiovascular Global. Importancia de su implementación sistemática en el Sistema Nacional de Salud]]></article-title>
<source><![CDATA[Rev Cubana Cardiol Cir Cardiovasc]]></source>
<year>2017</year>
<volume>23</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>308-11</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mancia]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Kreutz]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Brunström]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)]]></article-title>
<source><![CDATA[J Hypertens]]></source>
<year>2023</year>
<volume>41</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1874-2071</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
